Log in to search using one of your social media accounts:

 

Correspondence HPV control and resistance in the Middle East and north Africa

We thank Murat G ültekin and Baki Akgül,1 and we agree wholeheartedly with the fact that Islamic countries, and countries with more conservative sexual views based on religion in general, should implement educational projects in government-organised programmes. As we mentioned in our original Correspondence,2 the organisation of intervention policies based on awareness campaigns can be a very effective first step in the control of cervical cancer caused by HPV. However, a point that we would like to stress once more is that acceptance and implementation of these programmes, and in effect also vaccines, can b e faced with difficulties because of stigmatisation that is based on religious and traditional values.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research

Related Links:

Cervical cancer is the fourth most common cancer affecting women, with worldwide annual incidence and mortality rates of 528,000 and 266,000, respectively, according to the World Health Organization. It is well established that cervical cancer is predominantly caused by a persistent human papillomavirus (HPV) infection of cervical cells. Increasing numbers of studies have investigated HPV and cervical cancer, contributing greatly to the global knowledge and unraveling some of the critical questions regarding HPV transmission, infection, and prevention. However, despite these studies, our knowledge is far from complete and ...
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Source Type: research
DiscussionThe DNA microarray method can accurately detect known HPV subtypes simultaneously, but has limitations in detecting new subtypes. Vaccines can also be used to prevent HPV-associated OSCC in patients, so further studies on the prognosis and efficacy of vaccines should be undertaken.
Source: European Archives of Oto-Rhino-Laryngology - Category: ENT & OMF Source Type: research
The discovery of human papillomavirus, or HPV, as a major cause of many cancers — including cervical, anal, oropharyngeal, vaginal, vulvar and penile — and the subsequent development of prophylactic HPV vaccines was a revolution in cancer prevention.But 10 years after the vaccine ’s introduction, HPV vaccination rates among U.S. adolescents remain unacceptably low. Now, a five-year study led by UCLA cancer researcher Roshan Bastani will examine the comparative effectiveness of strategies designed to increase the number of adolescents who receive the HPV vaccine. The work i s being funded by a $6.6 million...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
ConclusionsThe currently used quadrivalent vaccine may be insufficient to give satisfactory HPV coverage in Rwanda. HPV Screening may be effective to identify women at risk of developing cervical cancer, particularly if provided to high‐risk patients.
Source: HIV Medicine - Category: Infectious Diseases Authors: Tags: Original Research Source Type: research
CONCLUSION: HPV 53 was the most prevalent genotype in healthy women. Distribution of HPV genotypes varied with cervical cytology and age. Our study provides important baseline data for the recently implemented national HPV vaccination program. PMID: 29185272 [PubMed - in process]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
Three nations blame social media for fall in number of girls given cervical cancer jabsHealth officials have become increasingly alarmed at campaigns aimed at blocking the take-up of the human papilloma virus (HPV) vaccine, which protects women against cervical cancer.Three leading nations have now seen major reductions in the take-up of the vaccine and a growing number of doctors fear its use could be blocked elsewhere, despite its capacity to provide protection against a condition that kills hundreds of thousands of women a year.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: HPV vaccine Health Vaccines and immunisation Women Life and style Science Society World news Source Type: news
Riko Muranaka awarded prize for efforts to explain jabs ’s safety amid scare campaigns which have seen Japanese vaccination rate fall from over 70% to 1%A Japanese doctor who has stood up to a campaign of misinformation around a common anti-cancer vaccine has won a prestigious prize for championing evidence in the face of hostility and personal threats.Riko Muranaka at Kyoto University was awarded the 2017 John Maddox prize on Thursday for her efforts to explain the safety of thehuman papilloma virus (HPV) vaccine amid strong opposition from anti-vaccine activists and a small group of academics.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Science prizes HPV vaccine Vaccines and immunisation Science and scepticism Health Society People in science Cervical cancer Source Type: news
Although high-risk (HR) human papilloma virus (HPV) infection is the primary causative factor for cervical squamous intraepithelial lesions and invasive cervical cancer, the epidemiology of potentially HR (pHR) and low-risk HPV still remains to be elucidated in HIV-infected women. In addition, the synergistic potential of the multiplicity of HPV infections harboured renders it difficult to model the impact of vaccines. This cross-sectional analysis of HIV-infected women explores the epidemiology of abnormal cytology, thereby profiling and pairing pHR/HR HPV genotypes. This cross-sectional analysis reports the findings of 5...
Source: European Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Research Papers: Gynecological Cancer Source Type: research
ConclusionThis type of analysis can be used to noninvasively study changes in immune cell recruitment in individual mice over time, potentially allowing improved application and combination of immunotherapies. Magn Reson Med, 2017. © 2017 International Society for Magnetic Resonance in Medicine.
Source: Magnetic Resonance in Medicine - Category: Radiology Authors: Tags: Full Paper Source Type: research
Conclusions: The low epithelial cell abnormality (EPCA) prevalence illustrated in this study argues against introduction of population-based HPV testing and vaccination. It calls for a more cost-effective measures in a country with limited resources, where a more widely available Pap-smear testing might suffice. PMID: 29172288 [PubMed]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: African Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Education | Government | Infectious Diseases | Men | Middle East Health | Vaccines